Literature DB >> 6240996

Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.

D Dantchev, G Balercia, C Bourut, A Anjo, R Maral, G Mathé.   

Abstract

Golden hamsters were submitted, three times a week during 4 weeks, to i.p. administration of an antracenedione, mitoxantrone (MTX), and 12 different anthracyclines, adriamycin (ADM), detorubicin (DTR), daunorubicin (DNR), 4'-epi-adriamycin (e-ADM), rubidazone (RBZ), aclacinomycin (ACM), N-trifluoroacetyladriamycin-14-valerate (AD-32), tetrahydropyranyl-adriamycin (THP-ADM), N-L-leucyl-daunorubicin (l-DNR), carminomycin (CAM), rubicyclamin (RBC) and N-trifluoroacetyl-adriamycin-14-9-hemiadipate (AD-143), at doses equivalent to 3/4 those which are optimally oncostatic on murine L1210 leukemia. The electron microscopic (EM) study of the myocardium showed that all studied drugs are cardiotoxic, but with different degree of cardiotoxicity. The histopathological study of the skin detect degenerative lesions with different degree of alopecia. According to the degree of their cardiotoxicity, skin toxicity, and general toxicity or mortality, all drugs studied are classified into 3 groups: 1st group, ADM, DNR, 1-DNR and RBZ, causing very severe cardiac alterations and alopecia (grade 2-3), and very high mortality, 2nd group, e-ADM, DTR, CAM RBC and MTX, with less severe cardiac alterations, and alopecia (grade 1-2), and always high mortality, and 3rd group, ACM, THP-ADM, AD-32 and AD-143, causing less severe myocardial alterations (grade 1-2), without alopecia (grade 0), and extremely low mortality and general toxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6240996

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline? A 1-year follow-up study of women.

Authors:  Y Cottin; C Touzery; B Coudert; S Richebourg; M Cohen; M Toubeau; P Louis; J E Wolf; F Brunotte
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Comparative effects of adriamycin and DNA-non-binding analogues on DNA, RNA, and protein synthesis in vitro.

Authors:  M Israel; J M Idriss; Y Koseki; V K Khetarpal
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Impairment of diastolic function during short-term anthracycline chemotherapy.

Authors:  Y Cottin; C Touzery; B Coudert; A Gilles; P Walker; J L Massing; M Toubeau; A Riedinger-Berriolo; D Caillot; P Louis
Journal:  Br Heart J       Date:  1995-01

4.  DNA-binding studies of valrubicin as a chemotherapy drug using spectroscopy and electrochemical techniques.

Authors:  Reza Hajian; Parvin Hossaini; Zahra Mehrayin; Pei Meng Woi; Nafiseh Shams
Journal:  J Pharm Anal       Date:  2017-01-11

5.  Fabrication of an electrochemical sensor for determination of doxorubicin in human plasma and its interaction with DNA.

Authors:  Reza Hajian; Zahra Tayebi; Nafiseh Shams
Journal:  J Pharm Anal       Date:  2016-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.